Artificial Blood Market by Component, Service, Application, and Region - Global Forecast to 2023
Artificial blood are synthetic substitutes of biological blood likely to harness a fresh horizon in transfusion medicine. These products are thought as replacement for red blood cells and act to serve few key functions of biological blood, such as acting as transportation medium for oxygen and co2 across the body cells. They could be made by chemical isolation or using recombinant biochemical technology. Although there are numerous products in advanced stages of clinical trials, the commercialization of artificial blood continues to be slow. The key concerns that marketers are addressing are safety, compatibility, and effectiveness of artificial blood.
Furthermore, the escalation in how many cases of road accidents, medical interventions, trauma cases, military wars, a smaller number of blood donors available and increase prevalence of blood disorders are the main factors driving the marketplace growth. However, limited shelf life and instability of artificial blood and stringent regulatory approval processes would be the factors restraining the growth of global Artificial Blood Market.
Upsurge in shortage of transfusable blood stocks, trauma death as a result of not enough availability of blood during operations and escalation in number of deaths by hemorrhagic shock ( it's an application of hypovolemic shock by which severe blood loss results in inadequate oxygen delivery at the cellular level) globally are driving the global artificial blood market through the forecast period.

Comments
Post a Comment